DOTA-Pep-1L
DOTA-Pep-1L is a peptide conjugated with DOTA and Pep-1L, a peptide that specifically targets the IL13RA2 receptor. DOTA-Pep-1L can be used for PET imaging and tumor-targeted therapy research[1].
Product Specifications
UNSPSC
12352100
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
O=C(N[C@@H](CS)C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CCSC)C(NCC(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CS)C(NCC(NCC(NCC(N[C@@H](CO)C(NCCCCCC(N[C@@H](CCCCN)C(N[C@@H](CCCCNC(CN3CCN(CCN(CCN(CC3)CC(O)=O)CC(O)=O)CC(O)=O)=O)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
Molecular Formula
C88H146N28O27S3
Molecular Weight
2124.47
References & Citations
[1]Sattiraju A, et al. IL13RA2 targeted alpha particle therapy against glioblastomas. Oncotarget. 2017 Jun 27;8 (26) :42997-43007.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882428-500 1x 500 µL
P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details